Raras
Buscar doenças, sintomas, genes...
Síndrome aneuploidia variada em mosaico
ORPHA:1052CID-10 · Q99.8CID-11 · LD7YDOENÇA RARA

A síndrome da aneuploidia variegada em mosaico (MVA) é uma anomalia cromossômica caracterizada por múltiplas aneuploidias em mosaico que leva a uma variedade de anormalidades fenotípicas e predisposição ao câncer.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A síndrome da aneuploidia variegada em mosaico (MVA) é uma anomalia cromossômica caracterizada por múltiplas aneuploidias em mosaico que leva a uma variedade de anormalidades fenotípicas e predisposição ao câncer.

Publicações científicas
34 artigos
Último publicado: 2026 Feb 16

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
41
pacientes catalogados
Início
Antenatal
+ neonatal
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: Q99.8
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (5)
0202010503
Cariótipo — bandas G, Q ou Rgenetic_test
0202010600
Pesquisa de microdeleções/microduplicações por FISHlab_test
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202010260
Dosagem de alfa-fetoproteína
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

😀
Face
24 sintomas
🧠
Neurológico
22 sintomas
🦴
Ossos e articulações
17 sintomas
📏
Crescimento
11 sintomas
❤️
Coração
10 sintomas
🧬
Pele e cabelo
7 sintomas

+ 62 sintomas em outras categorias

Características mais comuns

90%prev.
Ascite
Muito frequente (99-80%)
90%prev.
Distrofia muscular
Muito frequente (99-80%)
90%prev.
Opacidade corneana
Muito frequente (99-80%)
90%prev.
Catarata
Muito frequente (99-80%)
90%prev.
Epicanto
Muito frequente (99-80%)
90%prev.
Micrognatia
Muito frequente (99-80%)
190sintomas
Muito frequente (13)
Frequente (6)
Ocasional (45)
Sem dados (126)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 190 características clínicas mais associadas, ordenadas por frequência.

AsciteAscites
Muito frequente (99-80%)90%
Distrofia muscularMuscular dystrophy
Muito frequente (99-80%)90%
Opacidade corneanaCorneal opacity
Muito frequente (99-80%)90%
CatarataCataract
Muito frequente (99-80%)90%
EpicantoEpicanthus
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico34PubMed
Últimos 10 anos34publicações
Pico20196 papers
Linha do tempo
2026Hoje · 2026📈 2019Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

9 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant, Autosomal recessive.

CEP57Centrosomal protein of 57 kDaDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Centrosomal protein which may be required for microtubule attachment to centrosomes. May act by forming ring-like structures around microtubules. Mediates nuclear translocation and mitogenic activity of the internalized growth factor FGF2, but that of FGF1

LOCALIZAÇÃO

NucleusCytoplasmCytoplasm, cytoskeleton, microtubule organizing center, centrosome

VIAS BIOLÓGICAS (7)
Recruitment of mitotic centrosome proteins and complexesLoss of proteins required for interphase microtubule organization from the centrosomeLoss of Nlp from mitotic centrosomesRegulation of PLK1 Activity at G2/M TransitionAURKA Activation by TPX2
MECANISMO DE DOENÇA

Mosaic variegated aneuploidy syndrome 2

A severe developmental disorder characterized by mosaic aneuploidies, predominantly trisomies and monosomies, involving multiple different chromosomes and tissues. Affected individuals typically present with severe intrauterine growth retardation and microcephaly. Eye anomalies, mild dysmorphism, variable developmental delay, and a broad spectrum of additional congenital abnormalities and medical conditions may also occur. The risk of malignancy is high, with rhabdomyosarcoma, Wilms tumor and leukemia reported in several cases.

INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (2)
mosaic variegated aneuploidy syndrome 2mosaic variegated aneuploidy syndrome
HGNC:30794UniProt:Q86XR8
CENATACCentrosomal AT-AC splicing factorDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the minor spliceosome that promotes splicing of a specific, rare minor intron subtype (PubMed:34009673). Negative regulator of centrosome duplication (PubMed:31722219). Constrains centriole number by modulating the degradation of the centrosome-duplication-associated protein SASS6 in an acetylation-dependent manner. SIRT1 deacetylates CENATAC in G1 phase, allowing for SASS6 accumulation on the centrosome and subsequent procentriole assembly. The CENATAC acetylation level is restored

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, microtubule organizing center, centrosome

MECANISMO DE DOENÇA

Mosaic variegated aneuploidy syndrome 4

A form of mosaic variegated aneuploidy syndrome, a severe disorder characterized by mosaic aneuploidies, predominantly trisomies and monosomies, involving multiple different chromosomes and tissues. Affected individuals typically present with severe intrauterine growth retardation and microcephaly. Eye anomalies, mild dysmorphism, variable developmental delay, and a broad spectrum of additional congenital abnormalities and medical conditions may also occur. The risk of malignancy is high, with rhabdomyosarcoma, Wilms tumor and leukemia reported in several cases. MVA4 inheritance is autosomal recessive.

INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (1)
mosaic variegated aneuploidy syndrome 4
HGNC:HGNC:30460UniProt:Q86UT8
SMC5Structural maintenance of chromosomes protein 5Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Core component of the SMC5-SMC6 complex, a complex involved in repair of DNA double-strand breaks by homologous recombination. The complex may promote sister chromatid homologous recombination by recruiting the SMC1-SMC3 cohesin complex to double-strand breaks. The complex is required for telomere maintenance via recombination in ALT (alternative lengthening of telomeres) cell lines and mediates sumoylation of shelterin complex (telosome) components which is proposed to lead to shelterin complex

LOCALIZAÇÃO

NucleusChromosomeNucleus, PML bodyChromosome, telomere

VIAS BIOLÓGICAS (1)
SUMOylation of DNA damage response and repair proteins
MECANISMO DE DOENÇA

Atelis syndrome 2

A form of Atelis syndrome, an autosomal recessive neurodevelopmental disorder characterized by mild to severe developmental delay, learning difficulties, microcephaly, and growth restriction with short stature. Additional features include anemia, skin hyperpigmentation, ocular anomalies, congenital heart defects, and mild skeletal abnormalities. Death in childhood may occur. Patient cells show spontaneous chromosome breakage and chromosomal anomalies, hallmarked by segmented and dicentric chromosomes and mosaic variegated hyperploidy.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
61.5 TPM
Fallopian Tube
34.9 TPM
Linfócitos
33.9 TPM
Cervix Ectocervix
33.7 TPM
Nervo tibial
32.9 TPM
OUTRAS DOENÇAS (1)
Atelis syndrome 2
HGNC:HGNC:20465UniProt:Q8IY18
SLF2SMC5-SMC6 complex localization factor protein 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays a role in the DNA damage response (DDR) pathway by regulating postreplication repair of UV-damaged DNA and genomic stability maintenance (PubMed:25931565). The SLF1-SLF2 complex acts to link RAD18 with the SMC5-SMC6 complex at replication-coupled interstrand cross-links (ICL) and DNA double-strand breaks (DSBs) sites on chromatin during DNA repair in response to stalled replication forks (PubMed:25931565). Promotes the recruitment of the SMC5-SMC6 complex to DNA lesions (PubMed:25931565).

LOCALIZAÇÃO

NucleusNucleus, PML body

MECANISMO DE DOENÇA

Atelis syndrome 1

A form of Atelis syndrome, an autosomal recessive neurodevelopmental disorder characterized by mild to severe developmental delay, learning difficulties, microcephaly, and growth restriction with short stature. Additional features include anemia, skin hyperpigmentation, ocular anomalies, congenital heart defects, and mild skeletal abnormalities. Death in childhood may occur. Patient cells show spontaneous chromosome breakage and chromosomal anomalies, hallmarked by segmented and dicentric chromosomes and mosaic variegated hyperploidy.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
33.6 TPM
Ovário
33.0 TPM
Útero
24.3 TPM
Pituitária
24.1 TPM
Fallopian Tube
23.9 TPM
OUTRAS DOENÇAS (1)
Atelis syndrome 1
HGNC:HGNC:17814UniProt:Q8IX21
MAD1L1Mitotic spindle assembly checkpoint protein MAD1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the spindle-assembly checkpoint that prevents the onset of anaphase until all chromosomes are properly aligned at the metaphase plate (PubMed:10049595, PubMed:20133940, PubMed:29162720). Forms a heterotetrameric complex with the closed conformation form of MAD2L1 (C-MAD2) at unattached kinetochores during prometaphase, recruits an open conformation of MAD2L1 (O-MAD2) and promotes the conversion of O-MAD2 to C-MAD2, which ensures mitotic checkpoint signaling (PubMed:29162720) Sequest

LOCALIZAÇÃO

NucleusChromosome, centromere, kinetochoreNucleus envelopeCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasm, cytoskeleton, spindleCytoplasm, cytoskeleton, spindle poleCytoplasm

VIAS BIOLÓGICAS (6)
Amplification of signal from unattached kinetochores via a MAD2 inhibitory signalRHO GTPases Activate ForminsMitotic PrometaphaseEML4 and NUDC in mitotic spindle formationResolution of Sister Chromatid Cohesion
MECANISMO DE DOENÇA

Mosaic variegated aneuploidy syndrome 7 with inflammation and tumor predisposition

A form of mosaic variegated aneuploidy syndrome, a severe disorder characterized by mosaic aneuploidies, predominantly trisomies and monosomies, involving multiple different chromosomes and tissues. Affected individuals typically present with severe intrauterine growth retardation and microcephaly. Eye anomalies, mild dysmorphism, variable developmental delay, and a broad spectrum of additional congenital abnormalities and medical conditions may also occur. The risk of malignancy is high, with rhabdomyosarcoma, Wilms tumor and leukemia reported in several cases. MVA7 is an autosomal recessive form characterized by increased susceptibility to benign and malignant neoplasms beginning in early childhood. Affected individuals show dysmorphic facies and may have early developmental delay.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
18.9 TPM
Linfócitos
16.0 TPM
Skin Sun Exposed Lower leg
10.9 TPM
Baço
10.4 TPM
Cervix Ectocervix
10.0 TPM
OUTRAS DOENÇAS (2)
mosaic variegated aneuploidy syndrome 7 with inflammation and tumor predispositionprostate cancer, hereditary
HGNC:HGNC:6762UniProt:Q9Y6D9
BUB1Mitotic checkpoint serine/threonine-protein kinase BUB1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Serine/threonine-protein kinase that performs 2 crucial functions during mitosis: it is essential for spindle-assembly checkpoint signaling and for correct chromosome alignment. Has a key role in the assembly of checkpoint proteins at the kinetochore, being required for the subsequent localization of CENPF, BUB1B, CENPE and MAD2L1. Required for the kinetochore localization of PLK1. Required for centromeric enrichment of AUKRB in prometaphase. Plays an important role in defining SGO1 localization

LOCALIZAÇÃO

NucleusChromosome, centromere, kinetochore

VIAS BIOLÓGICAS (6)
Amplification of signal from unattached kinetochores via a MAD2 inhibitory signalRHO GTPases Activate ForminsMitotic PrometaphaseEML4 and NUDC in mitotic spindle formationResolution of Sister Chromatid Cohesion
MECANISMO DE DOENÇA

Microcephaly 30, primary, autosomal recessive

A form of microcephaly, a disease defined as a head circumference more than 3 standard deviations below the age, sex and ethnically matched mean. Brain weight is markedly reduced and the cerebral cortex is disproportionately small. MCPH30 is characterized by small head, poor overall growth, and global developmental delay with variably impaired intellectual development. Affected individuals may also have variable congenital anomalies, including atrial septal defect, dysmorphic facial features, tracheal stenosis, and anomalies of the skin and teeth.

OUTRAS DOENÇAS (3)
microcephaly 30, primary, autosomal recessivecolorectal cancermosaic variegated aneuploidy syndrome
HGNC:1148UniProt:O43683
BUB1BMitotic checkpoint serine/threonine-protein kinase BUB1 betaDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Essential component of the mitotic checkpoint. Required for normal mitosis progression. The mitotic checkpoint delays anaphase until all chromosomes are properly attached to the mitotic spindle. One of its checkpoint functions is to inhibit the activity of the anaphase-promoting complex/cyclosome (APC/C) by blocking the binding of CDC20 to APC/C, independently of its kinase activity. The other is to monitor kinetochore activities that depend on the kinetochore motor CENPE. Required for kinetocho

LOCALIZAÇÃO

CytoplasmNucleusChromosome, centromere, kinetochoreCytoplasm, cytoskeleton, microtubule organizing center, centrosome

VIAS BIOLÓGICAS (10)
Amplification of signal from unattached kinetochores via a MAD2 inhibitory signalRHO GTPases Activate ForminsMitotic PrometaphaseEML4 and NUDC in mitotic spindle formationResolution of Sister Chromatid Cohesion
OUTRAS DOENÇAS (4)
mosaic variegated aneuploidy syndrome 1premature chromatid separation traitcolorectal cancermosaic variegated aneuploidy syndrome
HGNC:1149UniProt:O60566
TRIP13Pachytene checkpoint protein 2 homologDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays a key role in chromosome recombination and chromosome structure development during meiosis. Required at early steps in meiotic recombination that leads to non-crossovers pathways. Also needed for efficient completion of homologous synapsis by influencing crossover distribution along the chromosomes affecting both crossovers and non-crossovers pathways. Also required for development of higher-order chromosome structures and is needed for synaptonemal-complex formation. In males, required fo

LOCALIZAÇÃO

MECANISMO DE DOENÇA

Mosaic variegated aneuploidy syndrome 3

A form of mosaic variegated aneuploidy syndrome, a severe disorder characterized by mosaic aneuploidies, predominantly trisomies and monosomies, involving multiple different chromosomes and tissues. Affected individuals typically present with severe intrauterine growth retardation and microcephaly. Eye anomalies, mild dysmorphism, variable developmental delay, and a broad spectrum of additional congenital abnormalities and medical conditions may also occur. The risk of malignancy is high, with rhabdomyosarcoma, Wilms tumor and leukemia reported in several cases. MVA3 inheritance is autosomal recessive.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
52.3 TPM
Linfócitos
24.4 TPM
Fibroblastos
17.5 TPM
Esôfago - Mucosa
5.9 TPM
Pituitária
3.0 TPM
OUTRAS DOENÇAS (4)
mosaic variegated aneuploidy syndrome 3oocyte maturation defect 9mosaic variegated aneuploidy syndromekidney Wilms tumor
HGNC:12307UniProt:Q15645
BUB3Mitotic checkpoint protein BUB3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Has a dual function in spindle-assembly checkpoint signaling and in promoting the establishment of correct kinetochore-microtubule (K-MT) attachments. Promotes the formation of stable end-on bipolar attachments. Necessary for kinetochore localization of BUB1. Regulates chromosome segregation during oocyte meiosis. The BUB1/BUB3 complex plays a role in the inhibition of anaphase-promoting complex or cyclosome (APC/C) when spindle-assembly checkpoint is activated and inhibits the ubiquitin ligase

LOCALIZAÇÃO

NucleusChromosome, centromere, kinetochore

VIAS BIOLÓGICAS (10)
Amplification of signal from unattached kinetochores via a MAD2 inhibitory signalRHO GTPases Activate ForminsMitotic PrometaphaseEML4 and NUDC in mitotic spindle formationResolution of Sister Chromatid Cohesion
OUTRAS DOENÇAS (1)
mosaic variegated aneuploidy syndrome
HGNC:1151UniProt:O43684

Variantes genéticas (ClinVar)

122 variantes patogênicas registradas no ClinVar.

🧬 CEP57: NM_014679.5(CEP57):c.600del (p.Thr201fs) ()
🧬 CEP57: NM_014679.5(CEP57):c.885+11C>G ()
🧬 CEP57: NM_014679.5(CEP57):c.383-120C>T ()
🧬 CEP57: NM_014679.5(CEP57):c.46-3566A>G ()
🧬 CEP57: NM_014679.5(CEP57):c.1064G>C (p.Gly355Ala) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 1,548 variantes classificadas pelo ClinVar.

851
697
VUS (55.0%)
Benigna (45.0%)
VARIANTES MAIS SIGNIFICATIVAS
BUB1B: NM_001211.6(BUB1B):c.2676C>T (p.Asn892=) [Uncertain significance]
BUB1B: NM_001211.6(BUB1B):c.1756C>T (p.Pro586Ser) [Uncertain significance]
CEP57: NM_014679.5(CEP57):c.630G>A (p.Met210Ile) [Uncertain significance]
BUB1B-PAK6: NM_001211.6(BUB1B):c.3023_3024del (p.Thr1008fs) [Uncertain significance]
TRIP13: NM_004237.4(TRIP13):c.1070A>G (p.Glu357Gly) [Uncertain significance]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome aneuploidia variada em mosaico

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
25 papers (10 anos)
#1

A novel CEP57 gene mutation in mosaic variegated aneuploidy syndrome 2: case report.

Journal of pediatric endocrinology &amp; metabolism : JPEM2026 Feb 16

Mosaic variegated aneuploidy syndrome 2 (MVA2) is an uncommon autosomal recessive genetic condition caused by mutations in the CEP57 gene. It is characterized by intrauterine growth restriction, severe short stature, facial dysmorphism, and skeletal abnormalities. Most affected individuals also show congenital cardiac defects and delayed development. To date, only 16 patients have been reported. We report a 6-year-old girl of consanguineous Moroccan parents, presenting with severe short stature, clinodactyly, and dysmorphic facial features including prominent forehead, triangular face, micro-retrognathia, and low set ears. Neurodevelopment was initially normal, but mild intellectual disability was then noted. Genetic testing including karyotype, array-CGH, and Silver-Russell syndrome were normal. Finally, whole exome sequencing revealed a homozygous c.834_844dupCAATGTTCAGC variant in CEP57, classified as likely pathogenic. Familial segregation confirmed heterozygosity in both parents and siblings. This report describes a novel homozygous variant of CEP57, expanding the clinical and genetic spectrum of MVA2 syndrome. Although, karyotype should be firstly requested if MVA is suspected, whole exome sequencing is crucial. Growth hormone therapy shows limited response in this syndrome, and the association with cancer predisposition should be further studied.

#2

[Genetic analysis of two fetuses with Mosaic variegated aneuploidy syndrome caused by compound heterozygous variants in BUB1B and its upstream regulatory elements and a literature Review].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics2025 Apr 10

To explore the genetic etiology of two fetuses with Mosaic variegated aneuploidy syndrome (MVA) in a pedigree. A 30-year-old pregnant woman, who presented at the Center for Medical Genetics and Prenatal Diagnosis of Shandong Maternal and Child Health Care Hospital on November 16, 2023, was enrolled. Clinical data of the pedigree were collected, and peripheral blood samples from the parents and amniotic fluid samples from the two fetuses were obtained for genomic DNA extraction. Whole exome sequencing (WES) was performed on both fetuses, followed by Sanger sequencing for familial validation and pathogenicity analysis of candidate variants. Chromosomal karyotyping of the parents was conducted to quantify the proportion of premature chromatid separation (PCS). This study was approved by the Medical Ethics Committee of Shandong Maternal and Child Health Care Hospital (Ethics No. 2024-034). Both fetuses exhibited structural brain anomalies and developmental delays during the second trimester. Amniocyte karyotyping revealed low-level mosaic aneuploidy involving multiple chromosomes, while chromosomal microarray analysis (CMA) showed no abnormalities. Pregnancy termination was performed for fetus 1. WES identified compound heterozygous variants in BUB1B, i.e., c.2363_2364del (p.S788Cfs*29) and ss804270619: G>A, in both fetuses. Sanger sequencing confirmed paternal inheritance of c.2363_2364del and maternal inheritance of ss804270619:G>A. According to the American College of Medical Genetics and Genomics (ACMG) and Clinical Genome Resource (ClinGen) Standards and Guidelines for the Interpretation of Sequence Variants, the c.2363_2364del variant was classified as likely pathogenic (PVS1 + PM2_Supporting). Parental karyotyping demonstrated PCS traits, with a higher proportion of abnormal metaphases in the father. The compound heterozygous variants c.2363_2364del (p.S788Cfs*29) and ss804270619: G>A in BUB1B may constitute the genetic etiology of the two MVA fetuses in this pedigree.

#3

BubR1 Controls Heart Development by Promoting Expression of Cardiogenesis Regulators.

Journal of the American Heart Association2025 Mar 18

Congenital heart defects are structural anomalies present at birth that can affect the function of the heart. Aneuploidy is a significant risk factor for congenital heart defects. Mosaic variegated aneuploidy syndrome, caused by mutations in Bub1b (encoding BubR1, a mitotic checkpoint protein), leads to congenital heart defects such as septal defects. However, the molecular rationale for how Bub1b mutations promote congenital heart defects associated with mosaic variegated aneuploidy syndrome remains unresolved. To study morphological, structural, and cellular consequences of BubR1 deletion in the heart, we crossed mice carrying conditional alleles of Bub1b with Nkx2.5-cre mice. Single-cell RNA sequencing was carried out to determine differentially expressed genes and biological processes in various cell types present in the developing heart. Trajectory analysis was carried out to determine the differentiation trajectory of BubR1 knockout embryonic hearts. Finally, CellChat analysis provided details on the major signaling interactions that were either absent or hyperactive in the BubR1 knockout heart. Here, we show that cardiac-specific BubR1 deletion causes embryonic lethality due to developmental stalling after cardiac looping with defects in cardiac maturation including chamber wall thickness, septation, and trabeculation. Single-cell transcriptomic profiling further revealed that the differentiation trajectory of cardiomyocytes is severely impacted with suppression of critical cardiogenesis genes. Hyperactivation of Wnt signaling in BubR1 knockout hearts indicated a disturbed homeostasis in cellular pathways essential for proper tissue morphogenesis of the heart. Taken together, these findings reveal that BubR1 is a crucial regulator of cardiac development in vivo, which ensures the proper timing of heart morphogenesis.

#4

A Distinctive Type of Mosaic Variegated Aneuploidy: Case Report and Review of the Literature.

American journal of medical genetics. Part A2025 Feb

Mosaic variegated aneuploidy (MVA) is an autosomal recessive disorder characterized by mosaic aneuploidies, predominantly trisomies, involving multiple different chromosomes and tissues. The proportion of aneuploid cells varies, and most patients present with intrauterine growth delay, microcephaly, and a broad spectrum of congenital abnormalities. We report a patient with a distinctive type of MVA discovered in bone marrow (BM) when she was 3-month-old due to neutropenia and hypocellular bone marrow. She was followed up for more than 20 years, and different trisomic cells were repeatedly discovered in different tissues, whereas her clinical picture has never been severe. The main sign remained intermittent neutropenia, not cyclic and often not too severe, occasionally with anemia and thrombocytopenia. Retromicrognathia was the only dysmorphic sign. Unlike other patients with MVA, the trisomies in all tissues involved almost invariably chromosomes 18 and 19. Therefore, the peculiarities of our patient were the clinical and the atypical cytogenetic pictures. Nevertheless, we looked for mutations in the seven causative genes of the known types of MVA, but the results were negative. Then, we analyzed the entire exome to find out other possible causing mutations, but also this attempt failed to discover a possible cause of this distinctive form of MVA.

#5

Mosaic variegated aneuploidy in development, ageing and cancer.

Nature reviews. Genetics2024 Dec

Mosaic variegated aneuploidy (MVA) is a rare condition in which abnormal chromosome counts (that is, aneuploidies), affecting different chromosomes in each cell (making it variegated) are found only in a certain number of cells (making it mosaic). MVA is characterized by various developmental defects and, despite its rarity, presents a unique clinical scenario to understand the consequences of chromosomal instability and copy number variation in humans. Research from patients with MVA, genetically engineered mouse models and functional cellular studies have found the genetic causes to be mutations in components of the spindle-assembly checkpoint as well as in related proteins involved in centrosome dynamics during mitosis. MVA is accompanied by tumour susceptibility (depending on the genetic basis) as well as cellular and systemic stress, including chronic immune response and the associated clinical implications.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC25 artigos no totalmostrando 34

2026

A novel CEP57 gene mutation in mosaic variegated aneuploidy syndrome 2: case report.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2025

[Genetic analysis of two fetuses with Mosaic variegated aneuploidy syndrome caused by compound heterozygous variants in BUB1B and its upstream regulatory elements and a literature Review].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2025

BubR1 Controls Heart Development by Promoting Expression of Cardiogenesis Regulators.

Journal of the American Heart Association
2025

A Distinctive Type of Mosaic Variegated Aneuploidy: Case Report and Review of the Literature.

American journal of medical genetics. Part A
2024

Mosaic variegated aneuploidy in development, ageing and cancer.

Nature reviews. Genetics
2024

Crystal structure of human Cep57 C-terminal domain reveals the presence of leucine zipper and the potential microtubule binding region.

Proteins
2024

Sudden unexpected postnatal collapse and BUB1B mutation: first forensic case report.

International journal of legal medicine
2024

RNA sequencing and target long-read sequencing reveal an intronic transposon insertion causing aberrant splicing.

Journal of human genetics
2024

Mosaic variegated aneuploidy syndrome with tetraploid, and predisposition to male infertility triggered by mutant CEP192.

HGG advances
2023

Mosaic variegated aneuploidy syndrome 2 with biallelic novel CEP57 splice site variation in Indian siblings: Expanding the clinical and molecular spectrum.

Clinical genetics
2022

Mosaic Variegated Aneuploidy Syndrome and Noonan Syndrome in the Same Family.

Molecular syndromology
2022

A novel CEP57 variant associated with mosaic variegated aneuploidy syndrome in a Chinese female presenting with short stature, microcephaly, brachydactyly, and small teeth.

Molecular genetics &amp; genomic medicine
2021

Mosaic Variegated Aneuploidy syndrome 2 caused by biallelic variants in CEP57, two new cases and review of the phenotype.

European journal of medical genetics
2021

Chromosomal mosaicism: Origins and clinical implications in preimplantation and prenatal diagnosis.

Prenatal diagnosis
2020

Follow-up of two adult brothers with homozygous CEP57 pathogenic variants expands the phenotype of Mosaic Variegated Aneuploidy Syndrome.

European journal of medical genetics
2020

Applications of Genome Editing Technology in Research on Chromosome Aneuploidy Disorders.

Cells
2020

Double homozygosity in CEP57 and DYNC2H1 genes detected by WES: Composite or expanded phenotype?

Molecular genetics &amp; genomic medicine
2020

BubR1 allelic effects drive phenotypic heterogeneity in mosaic-variegated aneuploidy progeria syndrome.

The Journal of clinical investigation
2019

Rhabdomyosarcoma with premature chromatid separation-mosaic variegated aneuploidy syndrome: Reduced-intensity chemotherapy.

Pediatrics international : official journal of the Japan Pediatric Society
2019

Long-term remission of bilateral Wilms tumors that developed from premature separation of chromatids/mosaic variegated aneuploidy syndrome due to bilateral nephrectomy and peritoneal dialysis.

Pediatric blood &amp; cancer
2019

Hematopoietic stem cell transplantation in a patient with type 1 mosaic variegated aneuploidy syndrome.

Orphanet journal of rare diseases
2019

The Cep57-pericentrin module organizes PCM expansion and centriole engagement.

Nature communications
2019

Nearly complete deletion of BubR1 causes microcephaly through shortened mitosis and massive cell death.

Human molecular genetics
2018

[Clinical features and genetic analysis of a child with mosaic variegated aneuploidy syndrome].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2018

Mosaic variegated aneuploidy syndrome caused by a CEP57 mutation diagnosed by whole exome sequencing.

Clinical case reports
2018

Mosaic-variegated aneuploidy syndrome mutation or haploinsufficiency in Cep57 impairs tumor suppression.

The Journal of clinical investigation
2019

A homozygous CEP57 c.915_925dupCAATGTTCAGC mutation in a patient with mosaic variegated aneuploidy syndrome with rhizomelic shortening in the upper and lower limbs and a narrow thorax.

European journal of medical genetics
2018

Prenatal diagnosis of premature chromatid separation/mosaic variegated aneuploidy (PCS/MVA) syndrome.

The journal of obstetrics and gynaecology research
2018

Germline mutations in the spindle assembly checkpoint genes BUB1 and BUB3 are infrequent in familial colorectal cancer and polyposis.

Molecular cancer
2017

PCS/MVA syndrome caused by an Alu insertion in the BUB1B gene.

Human genome variation
2017

Age-related decline in BubR1 impairs adult hippocampal neurogenesis.

Aging cell
2017

Polycystic ovary syndrome: A new phenotype in mosaic variegated aneuploidy syndrome?

Annales d'endocrinologie
2015

Ciliopathy in PCS (MVA) syndrome.

Oncotarget
2015

A case report of a fetus with mosaic autosomal variegated aneuploidies and literature review.

Annals of clinical and laboratory science

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome aneuploidia variada em mosaico.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome aneuploidia variada em mosaico

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. A novel CEP57 gene mutation in mosaic variegated aneuploidy syndrome 2: case report.
    Journal of pediatric endocrinology &amp; metabolism : JPEM· 2026· PMID 41700350mais citado
  2. [Genetic analysis of two fetuses with Mosaic variegated aneuploidy syndrome caused by compound heterozygous variants in BUB1B and its upstream regulatory elements and a literature Review].
    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics· 2025· PMID 40555658mais citado
  3. BubR1 Controls Heart Development by Promoting Expression of Cardiogenesis Regulators.
    Journal of the American Heart Association· 2025· PMID 40055864mais citado
  4. A Distinctive Type of Mosaic Variegated Aneuploidy: Case Report and Review of the Literature.
    American journal of medical genetics. Part A· 2025· PMID 39392177mais citado
  5. Mosaic variegated aneuploidy in development, ageing and cancer.
    Nature reviews. Genetics· 2024· PMID 39169218mais citado
  6. Crystal structure of human Cep57 C-terminal domain reveals the presence of leucine zipper and the potential microtubule binding region.
    Proteins· 2024· PMID 38699879recente
  7. Sudden unexpected postnatal collapse and BUB1B mutation: first forensic case report.
    Int J Legal Med· 2024· PMID 38664248recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:1052(Orphanet)
  2. MONDO:0000141(MONDO)
  3. GARD:3007(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q26492834(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome aneuploidia variada em mosaico
Compêndio · Raras BR

Síndrome aneuploidia variada em mosaico

ORPHA:1052 · MONDO:0000141
Prevalência
<1 / 1 000 000
Casos
41 casos conhecidos
Herança
Autosomal dominant, Autosomal recessive
CID-10
Q99.8 · Outras anomalias cromossômicas especificadas
CID-11
Início
Antenatal, Neonatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C4551972
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades